Lamivudine resistance in hepatitis B: mechanisms and clinical implications
- 1 April 2001
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 4 (2) , 118-128
- https://doi.org/10.1054/drup.2001.0190
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistanceJournal of Hepatology, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in Japanese patients with chronic hepatitis BJournal of Medical Virology, 1999
- Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapyHepatology, 1999
- Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the ‘a’ epitope of the surface antigen are sensitive to ganciclovirAntiviral Research, 1999
- Lamivudine treatment for acute hepatitis B after liver transplantationJournal of Hepatology, 1998
- Lamivudine resistance inimmunocompetent chronic hepatitis BJournal of Hepatology, 1997
- The implications of drug resistance for strategies of combination antiviral chemotherapyAntiviral Research, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Hepatitis B: global importance and need for controlVaccine, 1990